Vili Stage 1c ovarian cancer is usually clinically curable. Treatment methods mainly include surgical resection, chemotherapy, targeted therapy, radiotherapy and immunotherapy. The treatment plan needs to be formulated by a doctor based on factors such as the pathological type of tumor and the patient’s physical condition.
1. Surgical resection
Surgical treatment is the core method for stage 1c ovarian cancer. Depending on the extent of tumor spread, total hysterectomy and double adnexectomy, omentectomy or lymph node dissection can be selected. Early and complete resection of the disease can help improve survival rate, and postoperative pathological results will guide the formulation of subsequent adjuvant treatment plans.
2. Chemical drug treatment
Postoperative adjuvant chemotherapy can eliminate potential micrometastases. Commonly used regimens include paclitaxel combined with carboplatin, etc. Chemotherapy may cause bone marrow suppression, gastrointestinal reactions and other adverse reactions. Blood routine and liver and kidney functions need to be monitored regularly during treatment. Standardized chemotherapy cycles play an important role in preventing recurrence.
3. Targeted therapy
Targeted drugs targeting specific gene mutations, such as PARP inhibitors such as olaparib, can be used for maintenance treatment of patients with BRCA gene mutations. Targeted therapy needs to screen the suitable population through genetic testing and has the characteristics of accurately killing tumor cells. Common adverse reactions include anemia, fatigue, etc.
4. Radiotherapy
Local radiotherapy is mostly used to treat residual disease or recurrence after surgery, and techniques such as intensity-modulated radiotherapy can be used to accurately irradiate target areas. Radiotherapy may cause complications such as radiation enteritis. During treatment, attention must be paid to protecting normal tissues and strengthening nutritional support.
5. Immunotherapy
Immune checkpoint inhibitors such as PD-1/PD-L1 inhibitors are suitable for advanced cases with specific molecular characteristics, and biomarker testing is required before treatment. Immunotherapy may cause immune-related adverse reactions, and abnormal immune reactions need to be closely monitored and dealt with promptly.
Patients with stage 1c ovarian cancer require lifelong follow-up after treatment. It is recommended to review tumor markers and imaging examinations every 3 months. The re-examination interval can be gradually extended after 2 years. You should maintain a balanced diet on a daily basis, properly supplement high-quality protein and fresh vegetables and fruits, and avoid high-fat diet. Regular gentle exercise such as Tai Chi can help restore physical fitness, while maintaining a positive attitude and dealing with treatment-related side effects promptly. Strictly following the doctor's instructions to complete standardized treatment and regular review can significantly improve the prognosis.
